Jones Financial Companies’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Buy |
27,601
+6,431
| +30% | +$449K | ﹤0.01% | 764 |
|
|
2025
Q1 | $1.56M | Buy |
21,170
+4,942
| +30% | +$365K | ﹤0.01% | 723 |
|
|
2024
Q4 | $1.06M | Buy |
16,228
+3,066
| +23% | +$201K | ﹤0.01% | 725 |
|
|
2024
Q3 | $1.02M | Buy |
13,162
+6,612
| +101% | +$513K | ﹤0.01% | 606 |
|
|
2024
Q2 | $511K | Buy |
6,550
+4,633
| +242% | +$361K | ﹤0.01% | 562 |
|
|
2024
Q1 | $130K | Buy |
1,917
+1,411
| +279% | +$95.6K | ﹤0.01% | 539 |
|
|
2023
Q4 | $34.1K | Buy |
506
+235
| +87% | +$15.8K | ﹤0.01% | 523 |
|
|
2023
Q3 | $18.4K | Sell |
271
-739
| -73% | -$50K | ﹤0.01% | 442 |
|
|
2023
Q2 | $72.3K | Buy |
1,010
+657
| +186% | +$47K | ﹤0.01% | 334 |
|
|
2023
Q1 | $24.5K | Sell |
353
-399
| -53% | -$27.7K | ﹤0.01% | 405 |
|
|
2022
Q4 | $51K | Sell |
752
-3
| -0.4% | -$203 | ﹤0.01% | 346 |
|
|
2022
Q3 | $41K | Hold |
755
| – | – | ﹤0.01% | 337 |
|
|
2022
Q2 | $50K | Buy |
755
+486
| +181% | +$32.2K | ﹤0.01% | 334 |
|
|
2022
Q1 | $18K | Sell |
269
-3,405
| -93% | -$228K | ﹤0.01% | 446 |
|
|
2021
Q4 | $214K | Buy |
3,674
+3,230
| +727% | +$188K | ﹤0.01% | 244 |
|
|
2021
Q3 | $27K | Buy |
444
+116
| +35% | +$7.05K | ﹤0.01% | 396 |
|
|
2021
Q2 | $20K | Sell |
328
-952
| -74% | -$58K | ﹤0.01% | 398 |
|
|
2021
Q1 | $64K | Buy |
1,280
+881
| +221% | +$44.1K | ﹤0.01% | 320 |
|
|
2020
Q4 | $20K | Buy |
+399
| New | +$20K | ﹤0.01% | 365 |
|
|
2013
Q3 | – | Sell |
-4,750
| Closed | -$112K | – | 722 |
|
|
2013
Q2 | $112K | Buy |
+4,750
| New | +$112K | ﹤0.01% | 247 |
|